Pain patients who got relief from pregabalin, or Lyrica, were likely to respond within an average of three to four weeks, according to research in the Journal of Pain Research. The analysis included data from five studies of patients with post-herpetic neuralgia, diabetic peripheral neuropathy, fibromyalgia and spinal cord injuries.
Scientists at the University of Kansas Medical Center found that aerobic exercise reduced the perception of pain interference in daily activities among patients with diabetic peripheral neuropathy. The exercise did not change pain intensity, however. The study was published online in the journal Pain Medicine.
Dutch researchers found that spinal cord stimulation was able to reduce the pain experienced by patients with diabetic peripheral neuropathy. Although the invasive approach can cause such complications as infections, hematomas and cerebrospinal fluid leak, its efficacy makes it a viable treatment of last resort, according to the researchers.
A new study in the journal Diabetes Care using ultrasound has found that decompression of the tibial nerve did not reduce its cross-sectional area in patients with painful diabetic peripheral neuropathy. "We're not suggesting that decompression isn't worthwhile, only that we didn't find an effect of surgery on CSA using ultrasound," said study coauthor Marita Schouten. The authors plan a second paper on clinical outcomes such as relief from pain and tingling.
A Massachusetts-based company has created a device to stimulate nerves and help control the often burning and stabbing pain caused by diabetic peripheral neuropathy. The Sensus, controlled by a single button, can be worn on the calf and deliver stimulation as long as eight to 16 hours a day, although some patients may need only one daily treatment, NeuroMetrix CEO Shai Gozani said. "We wanted to make this as easy to use as taking a pill," he said.